Browsing by Author 문영철

Jump to:
All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 30 of 129

Issue DateTitleAuthor(s)Type
2009A case of wernicke's encephalopathy following fluorouracil-based chemotherapy이순남; 성주명; 이경은; 문영철; 남은미Article
2012A genome-wide single-nucleotide polymorphism-array can improve the prognostic stratification of the core binding factor acute myeloid leukemia허정원; 문영철Article
2013A proposal for improvement in the utilization rate of banked cord blood문영철Note
2015A prospective, multicenter, observational study of long-term decitabine treatment in patients with myelodysplastic syndrome문영철Article
2017A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalan-prednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myeloma문영철Article
2012ABL1 deletion without BCR/ABL1 rearrangement is originated from a large-sized 9q deletion정화순; 성주명; 허정원; 문영철Letter
2016ACQUIRED HLA-B*40:02 MUTATION LEADING TO FRAME SHIFT IN DIOPATHIC APLASTIC ANEMIA허정원; 문영철Meeting Abstract
2009Acute fibrinous and organizing pneumonia following hematopoietic stem cell transplantation이순남; 성순희; 성주명; 김유경; 이경은; 문영철Article
2013Acute promyelocytic leukemia with a rare PML Exon 4/RARA exon 3 fusion transcript variant정화순; 성주명; 허정원; 문영철Article
2012Additional genomic aberrations identified by single nucleotide polymorphism array-based karyotyping in an acute myeloid leukemia case with isolated del(20q) abnormality정화순; 성주명; 허정원; 문영철Article
2012ADDITIONAL GENOMIC ABERRATIONS IDENTIFIED BY SNP-ARRAY BASED KARYOTYPING IN CASES WITH ISOLATED DEL(9Q) OR DEL(20Q) ABNORMALITY정화순; 성주명; 허정원; 문영철Meeting Abstract
2003Adherent cells generated during long-term culture of human umbilical cord blood CD34+ cells have characteristics of endothelial cells and beneficial effect on cord blood ex vivo expansion이순남; 이미애; 서정완; 정화순; 성주명; 유은선; 허정원; 이경은; 문영철Article
2011Adverse prognostic impact of abnormal lesions detected by genome-wide single nucleotide polymorphism array-based karyotyping analysis in acute myeloid leukemia with normal karyotype허정원; 문영철Article
2008ANALYSIS OF CHARACTERISTICS IN CURATIVELY RESECTED STAGE IV GASTRIC CANCER PATIENTS문영철Meeting Abstract
2015Azacitidine Pre-Treatment Followed by Reduced-Intensity Stem Cell Transplantation in Patients with Higher-Risk Myelodysplastic Syndrome문영철Article
2011Bortezomib Induction Followed by ASCT in Patients with Multiple Myeloma: Achievement of Response After Induction and Achieving CR Post-ASCT Are Both Important Prognostic Markers문영철Meeting Abstract
2017BORTEZOMIB-MELPHALAN-PREDNISONE VERSUS MP AS INITIAL TREATMENT FOR VERY ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA문영철Meeting Abstract
2015Calreticulin mRNA expression and clinicopathological characteristics in acute myeloid leukemia정화순; 성주명; 허정원; 문영철; 정혜선Article
2007CD34, RAB20, DLK1, PU.1 and GFI1 mRNA expression in myelodysplastic syndrome홍기숙; 정화순; 성주명; 허정원; 문영철Meeting Abstract
2009CD34, RAB20, PU.1 and GFI1 mRNA expression in myelodysplastic syndrome홍기숙; 이미애; 정화순; 성주명; 허정원; 문영철Article
2016Change of health-related profiles after Imatinib cessation in chronic phase chronic myeloid leukemia patients문영철Article
2014Changes in osteoblastic activity in patient who received bortezomib as second line treatment for plasma cell myeloma: A prospective multicenter study문영철Article
2011Characteristics of myelodysplastic syndrome, unclassifiable by WHO classification 2008정화순; 성주명; 허정원; 문영철Letter
2008Characterization of phenotypically distinct B-cell subsets and receptor-stimulated mitogen-activated protein kinase activation in human cord blood B cells성주명; 이종란; 문영철Article
2014Chromosome 13 deletion and hypodiploidy on conventional cytogenetics are robust prognostic factors in Korean multiple myeloma patients: Web-based multicenter registry study문영철Article
2014Clinical factors associated with response or survival after chemotherapy in patients with Waldenström macroglobulinemia in Korea문영철Article
2012Clinical features and outcomes of Hodgkin's lymphoma in Korea: Consortium for Improving Survival of Lymphoma (CISL)문영철Article
2009Clinical features and survival outcomes in patients with multiple myeloma: Analysis of web-based data from the korean myeloma registry문영철Article
2013Clinical features and treatment outcome of primary systemic light-chain amyloidosis in Korea: Results of multicenter analysis문영철Article
2017CLINICAL IMPACT BY 24 MONTHS ACCORDING TO BCR/ABL1 TRANSCRIPT LEVEL AT 3 AND 6 MONTHS IN NEWLY DIAGNOSED CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH RADOTINIB 300MG BID OR IMATINIB문영철Meeting Abstract

BROWSE